lobbying_activities: 3382591
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
This data as json
| id | filing_uuid | filing_type | registrant_name | registrant_id | client_name | filing_year | filing_period | issue_code | specific_issues | government_entities | income_amount | expense_amount | is_no_activity | is_termination | received_date |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 3382591 | b05f50e3-97af-429a-8555-62a1231998f0 | Q2 | WAXMAN STRATEGIES | 401103693 | 340B HEALTH | 2025 | second_quarter | PHA | Issues affecting the 340B drug pricing program; Appropriations for 340B program. | HOUSE OF REPRESENTATIVES,SENATE | 39000 | 0 | 0 | 2025-07-15T10:39:38-04:00 |